<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00135070</url>
  </required_header>
  <id_info>
    <org_study_id>H.P.I.1</org_study_id>
    <nct_id>NCT00135070</nct_id>
  </id_info>
  <brief_title>Hospital In-Patient Insulin Study</brief_title>
  <official_title>A Randomised Study Comparing Continuous Intravenous Insulin Infusion With Subcutaneous Insulin Analogues in Hospitalised Patients With Type II Diabetes and Hyperglycaemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Royal Bournemouth Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Royal Bournemouth Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hyperglycaemia has been shown to increase morbidity and mortality in patients with critical
      illness, myocardial infarction and stroke. This study aims to look at patients with
      hyperglycaemia and reduce their blood sugar levels using differing combinations of
      subcutaneous and intravenous insulin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomised trial involving patients with type II diabetes who are brought into the
      hospital with a problem other than a diabetic emergency. Patients will be included, who have
      a blood sugar &gt; than 17mmols. They will be randomised to one of two groups and either given
      intravenous or subcutaneous insulin. Outcome measures are length of stay, glucose control and
      comparison of the two regimens. Cost implications will also be analysed.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    No documentation with MHRA to support clinical trial of a medicinal product.
  </why_stopped>
  <start_date>July 2005</start_date>
  <completion_date type="Actual">June 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose control</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
  </secondary_outcome>
  <enrollment type="Actual">41</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Detemir</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type II diabetes

          -  Blood glucose &gt; 17mmols

        Exclusion Criteria:

          -  Type I diabetes

          -  Hyperosmolar non-ketotic coma (HONK)

          -  Diabetic ketoacidosis (DKA)

          -  Myocardial infarction (MI)

          -  Vomiting
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Kerr, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Royal Bournemouth Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Royal Bournemouth Hospital</name>
      <address>
        <city>Bournemouth</city>
        <state>Dorset</state>
        <zip>BH7 7DW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2005</study_first_submitted>
  <study_first_submitted_qc>August 23, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2005</study_first_posted>
  <last_update_submitted>April 27, 2007</last_update_submitted>
  <last_update_submitted_qc>April 27, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 1, 2007</last_update_posted>
  <keyword>Diabetes Mellitus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

